• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> HLA-DR Antibody (MHC II)

HLA-DR Antibody (MHC II) [clone LN3] (V2586)

  Catalog No Formulation Size Price (USD)  
Image V2586-100UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 100 ug 539
Image
V2586-20UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 20 ug 249
Image
V2586SAF-100UG 1 mg/ml in 1X PBS; BSA free, sodium azide free 100 ug 539
Image
V2586IHC-7ML Prediluted in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide; *For IHC use only* 7 ml 539
Bulk quote request
Immunofluorescent staining of human Ramos cells with HLA-DR antibody (clone LN3, green) and Reddot nuclear stain (red).
IHC staining of FFPE human tonsil tissue with HLA-DR antibody (clone LN3). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA for 20 min and allow to cool before testing.
IHC staining of FFPE human histiocytoma tissue with HLA-DR antibody (clone LN3). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA for 20 min and allow to cool before testing.
Western blot testing of human Ramos cell lysate with HLA-DR antibody (clone LN3). Expected molecular weight ~30 kDa.
Western blot testing of human Ramos and spleen cell lysate with HLA-DR antibody (clone LN3). Expected molecular weight ~30 kDa.
Flow cytometry staining of human Raji cells with HLA-DR antibody; Red=isotype control, Blue= HLA-DR antibody.
Availability 1-3 business days
Species Reactivity Human
Format Purified
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG2b, kappa
Clone Name LN3
Purity Protein G affinity chromatography
UniProt P01911
Localization Cytoplasmic, membranous
Applications Flow Cytometry : 1-2ug/million cells
Immunofluorescence : 1-3ug/ml
Western Blot : 2-4ug/ml
Immunohistochemistry (FFPE) : 1-2ug/ml for 30 min at RT
Limitations This HLA-DR antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

HLA-DR Antibody (clone LN3) recognizes human HLA-DR, a major histocompatibility complex class II (MHC II) protein essential for antigen presentation to CD4-positive T lymphocytes. HLA-DR is expressed on dendritic cells, macrophages, B cells, and thymic epithelial cells, and can be upregulated on additional cell types during immune activation. Functionally, HLA-DR is a heterodimer consisting of a non-polymorphic alpha chain (DRA) and a highly polymorphic beta chain (DRB), which together form the peptide-binding groove used to present processed extracellular peptides to helper T cells. This antigen presentation pathway plays a fundamental role in adaptive immunity, immune tolerance, and the pathogenesis of autoimmune and inflammatory diseases.

Both HLA-DR chains are type I membrane glycoproteins that assemble in the endoplasmic reticulum with the invariant chain (CD74), which directs them into endosomal compartments for peptide loading. After proteolytic removal of CD74 and editing by HLA-DM, peptide-loaded HLA-DR is transported to the cell surface. Because of its involvement in antigen presentation, HLA-DR serves as a widely used marker of antigen-presenting cell activation in immunohistochemistry, flow cytometry, and tissue immunopathology. Elevated HLA-DR expression is characteristic of activated microglia, inflammatory infiltrates, and certain neoplasms, making it an important readout of immune microenvironment status.

Clone LN3 is a well-established monoclonal antibody that detects a conserved, non-polymorphic HLA-DR epitope. The precise amino acid epitope has not been mapped in the primary literature, but two peer-reviewed findings provide insight into its chain-level specificity. First, a fetal tissue immunohistochemistry study published in the Journal of Histochemistry and Cytochemistry states that LN3 recognizes 'a non-polymorphic portion of the HLA-DR alpha chain' making this the only published chain-specific assignment for LN3. This aligns with the biology of the DRA chain, which is largely non-polymorphic across individuals.

Second, western blot data from a microglial activation study in MPTP-treated primates report that LN3 detects a 29-33 kDa band in human tissues. This observed molecular weight corresponds more closely to the expected migration of the DRB beta chain (~26-28 kDa) than to the somewhat larger DRA alpha chain (~33-36 kDa). The authors did not perform chain-specific immunoprecipitation or mutagenesis, so their data do not contradict the alpha-chain assignment; instead, they suggest that LN3 may recognize an epitope whose conformational or fixation-resistant properties behave differently under denaturing SDS-PAGE conditions. In other words, LN3 identifies a non-polymorphic HLA-DR determinant in situ, while its WB target size falls within the beta-chain range.

Taken together, published findings support that clone LN3 binds a non-polymorphic HLA-DR epitope that has been described as alpha-chain associated in immunohistochemistry, yet produces a western blot band in the beta-chain size range. No peer-reviewed study has performed definitive epitope mapping, and the chain-level specificity of LN3 remains incompletely resolved. Accordingly, LN3 is best characterized as a well-validated pan-HLA-DR antibody whose recognized determinant is conserved across HLA-DR allotypes, with both alpha- and beta-chain evidence present in the literature.

Application Notes

Optimal dilution of the HLA-DR antibody should be determined by the researcher.

1. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Immunogen

Activated human peripheral blood mononuclear cells were used as the immunogen for the HLA-DR antibody.

Storage

Store the HLA-DR antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.